GSK3 inhibitor ameliorates steatosis through the modulation of mitochondrial dysfunction in hepatocytes of obese patients. Yaqiong Li et al
Published: 9 March 2021| Version 2 | DOI: 10.17632/54rxxvrwxr.2
Contributor:
Haiyan ZhangDescription
All original, unprocessed images of western blot in the paper.
Files
Categories
Western Blot